Results 81 to 90 of about 10,827 (201)
The revolving door between hospital and community: extended-spectrum beta-lactamase-producing Escherichia coli in Dublin. [PDF]
BACKGROUND: Escherichia coli that produce extended-spectrum beta-lactamases (ESBLs) are an increasing cause of healthcare-associated infection, and community healthcare facilities may be a reservoir for important epidemic clones.
Burke, Liam +2 more
core +2 more sources
The high mortality and morbidity resulting from diarrhoeal cases worldwide are associated with the increasing incidence of antimicrobial resistance (AMR) and represent a serious public health concern. Cattle are a major reservoir of AMR organisms, and faecal shedding may facilitate their transmission into the food chain.
Tesleem Olatunde Abolarinwa +10 more
wiley +1 more source
The clbA gene, encoding the genotoxin colibactin, was present in 13.0% of Multidrug‐resistant (MDR) E. coli isolates, with a significantly higher prevalence observed in clinical patients (25.0%) compared to other host groups. clbA‐positive isolates demonstrated a markedly enhanced resistance profile, including 100% resistance to critical antibiotics ...
Soma Kanta Baral +4 more
wiley +1 more source
Antibacterial Potential of Actinomycete Extracts Against Multidrug‐Resistant Escherichia coli in Babil Province, Iraq. ABSTRACT The increasing prevalence of multidrug‐resistant (MDR) uropathogenic Escherichia coli (UPEC) strains, particularly those producing β‐lactamase enzymes, complicates urinary tract infection (UTI) treatment and poses a ...
Hoda Khaledi, Nour Oude Obeid
wiley +1 more source
OXA-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli [PDF]
Background ESBL-producing Escherichia coli have expanded globally since the turn of the century and present a major public health issue. Their in vitro susceptibility to penicillin/inhibitor combinations is variable, and clinical use of these ...
Cleary, Paul +8 more
core +3 more sources
The extraintestinal pathogenic Escherichia coli (ExPEC) H30 subclone of sequence type 131 (ST131-H30) has emerged abruptly as a dominant lineage of ExPEC responsible for human disease.
Timothy J. Johnson +11 more
doaj +1 more source
Increase in bacteraemia cases in the East Midlands region of the UK due to MDREscherichia coliST73: high levels of genomic and plasmid diversity in causative isolates [PDF]
Objectives: To determine the population structure of E. coli ST73 isolated from human bacteraemia and urinary tract infections. Methods: The genomes of 22 E.coli ST73 isolates were sequenced using the Illumina HiSeq platform.
Alhashash, F +5 more
core +4 more sources
NanoMLST is a workflow suggested as a viable alternative to high‐throughput ST determination for ESKAPE + E pathogens using ONT next‐generation sequencing. ABSTRACT Multi‐Locus Sequence Typing (MLST) is a key method for allocation of Sequence Types (STs) for bacterial isolates. Traditionally, this is performed by the Sanger sequencing method, which can
Isabel García‐Pérez +10 more
wiley +1 more source
Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type ST131 and Non-ST131 Clones: Comparison of Demographic Data, Clinical Features, and Mortality [PDF]
ABSTRACT Escherichia coli producing the highly virulent, multidrug-resistant, CTX-M-15 extended-spectrum β-lactamase (ESBL), sequence type 131 (ST131), has emerged on three continents since the late 2000s. We described the molecular epidemiology, clinical features, and outcome of ESBL-producing E. coli
Hsing-Chun, Chung +8 more
openaire +2 more sources
Yewei Fang,1 Shuan Tao,2 Huimin Chen,2 Yao Xu,3 Luyan Chen,4 Wei Liang1 1Department of Clinical Laboratory, The First Affiliated Hospital of Ningbo University, Ningbo, People’s Republic of China; 2School of Medicine, Jiangsu University, Zhejiang, People ...
Fang Y +5 more
doaj

